there was no subscription for new shares today, and a total of four new shares were listed, namely: youningwei and oni electronics on GEM, Kelun electronics and Nanmo biology on Kechuang board.
youningwei is the agent of China’s life science reagents. The company has accumulated a wide range of high-quality customer groups, such as Qingbei Fujiao, Chinese Academy of Sciences, Wuxi Apptec Co.Ltd(603259) , Zhongshan Hospital Affiliated to Fudan University, etc. However, the company currently relies on third-party brands and has no independent brands.
oney electronics is a consumer Internet of things intelligent terminal service provider based on ODM mode, provides ODM customization for Qihoo 360, owlet baby and other domestic and foreign enterprises. However, it is difficult for PC / TV external camera products to grow in future performance.
Gallen electronics is the first EDA enterprise listed in China and serves the world’s leading wafer factories. The company’s products are widely used by nine of the world’s top ten wafer foundries, including TSMC, Samsung Electronics, liandian, lattice core, etc.
namo bio currently belongs to the “new track” in China, and there is no similar company in a shares. Backed by the Chinese Academy of Sciences, the company is the leader in the field of model animals in China and ranks first in the field of customized models and model breeding and feeding in China. the company has established good cooperative relations with well-known colleges and universities such as the resumption of diplomatic relations in northern Qing Dynasty, well-known hospitals such as Ruijin, Zhongshan and Huashan, well-known innovative drug R & D companies such as YaoMing biology and Xinda biology, and cro companies.
For Nanmo biology, Guotai Junan Securities Co.Ltd(601211) suggests that the Chinese market started late but also grew rapidly. It is estimated that the animal model market will reach US $1.5 billion in 2023, including US $1 billion in genetically modified animal model market. With the rapid growth of the industry, the company, as a leader in the industry, has great potential for performance growth.
genetically modified animal model industry is an emerging industry in China. Under the background of the continuous increase of China’s biomedical R & D expenditure and the rapid growth of cro industry, the industry market scale continues to expand, and it is expected to grow to US $1 billion in 2023. the market of genetically modified animal models is relatively scattered and the industry concentration is low.
(Financial Associated Press)
